Phathom Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Name: Phathom Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Phathom Pharmaceuticals Inc
Rating: 2.18025
Author: Trendlyne DVM scores

about

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...

14.85 0.23 (1.57%)

571.95% Gain from 52W Low

974.9K

XNAS Volume

XNAS 13 Nov, 2025 4:30 PM (EST)

Board Meeting

The next board meeting for Phathom Pharmaceuticals Inc is on 18 Nov 2025 for the purpose of Jefferies Global Healthcare Conference See details

Not Eligible

Expensive Valuation

8.5 / 100

Technically Bullish

78.7 / 100

1Yr Price target upside is 56%

8 analysts

Phathom Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Phathom Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...

571.95% Gain from 52W Low

SWOT Analysis

Phathom Pharmaceuticals Inc Live Price Chart